Clinical Trial Update: Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

View source ↗

Summary

A completed retrospective study to validate a chemoresponse marker test for ovarian, peritoneal, and fallopian tube cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Precision Therapeutics | Conditions: Ovarian Cancer, Peritoneal Cancer | Status: COMPLETED